ProCE Banner Activity

Optimizing LA ART for Sexual and Gender Minorities in Latin America: Insights From CROI 2025

Conference Coverage
Clinical Thought

Learn how the initial results from the ImPrEP CAB Brasil study, presented at CROI 2025, demonstrate how long-acting PrEP could help address challenges associated with daily oral PrEP, particularly among youth from sexual and gender minorities.

Released: April 04, 2025

Expiration: April 03, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Disclosure

Primary Author

Emilia M. Jalil, MD, PhD: researcher (paid to institution): Merck Sharp & Dohme.